Article Information
History
- September 22, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shota Yamauchi1,*,
- Yuki Sugiura2,
- Junji Yamaguchi3,4,
- Xiangyu Zhou1,
- Takeru Odawara1,
- Shunsuke Fukaya1,
- Isao Naguro1,
- Yasuo Uchiyama4 and
- Hidenori Ichijo1,*
- 1Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
- 2Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan
- 3Laboratory of Morphology and Image Analysis, Biomedical Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan
- 4Department of Cellular and Molecular Neuropathology, Juntendo University Graduate School of Medicine, Tokyo, Japan
- ↵*Corresponding author. Email: yamauchi-s{at}umin.ac.jp (S.Y.); ichijo{at}mol.f.u-tokyo.ac.jp (H.I.)